OpenAI Lets Health, Finance Ads Into ChatGPT Chats
OpenAI quietly stopped blanket-blocking ads near medical, legal and financial topics in April, and new SE Ranking data shows just how often they're showing up.
Key takeaways
- ChatGPT served ads on 28.69% of commercial healthcare prompts, over 10x the 2.64% rate SE Ranking found in Google's AI Mode.
- OpenAI's ad policy, last updated August 10, now separates placement rules (where ads run) from buyer eligibility (who can advertise).
- Health advertisers like insurers, dental, supplements and hospitals can now buy in via manual review; legal services ads remain banned except general legal education.
- OpenAI's rules have changed four times since March, and the pilot expanded to the UK, Mexico, Brazil, Japan and South Korea on August 11.
- Marketers in regulated verticals should treat ChatGPT ad plans as a moving target and recheck eligibility before every campaign push.
What Changed
OpenAI has stopped categorically blocking ads near medical, legal and financial advice inside ChatGPT, and a new SE Ranking analysis shows the shift is already showing up in live traffic. Ads appeared on 28.69% of commercial healthcare prompts the firm tested, according to the report covered by Search Engine Journal, more than 10 times the 2.64% rate the same firm recorded in Google's AI Mode.
The change traces back to April, when OpenAI's changelog described a 'more precise approach' to ad placement and noted that medical, legal and financial advice contexts are no longer blocked by default. Sensitive conversations, the kind covering mental and personal health, remain off limits. That distinction matters more than it sounds: OpenAI's current policy separates where an ad can run from who is allowed to buy one.
Share of commercial healthcare prompts that returned an ad in ChatGPT
SE Ranking, July 23, 2026 data
The Fine Print Buyers Need
OpenAI's ad policies page, last updated August 10, lists health insurance, dental services, supplements, vision products, medical testing, and hospitals and urgent care among the categories eligible for manual-review approval. Legal services go the other way: ads for legal advice, court-related work and similar services are barred outright, with an exception for general legal education. Political ads stay completely banned.
SE Ranking's data can't confirm whether ads landed inside the personal health conversations OpenAI's placement rules are meant to protect; it only tracks prompts the firm sorted into a healthcare niche. For teams weighing whether ChatGPT belongs in the media plan alongside other AI surfaces, our breakdown of OpenAI's ad credit rules is a useful next stop, and regulated-vertical marketers should also revisit the FTC's case against Hims & Hers over sensitive health data before signing off on any health campaign near AI chat surfaces.
Track every AI ad platform shift before your next media buy.
Frequently asked questions
Yes, but only after manual review. OpenAI's policy lists eligible health categories like health insurance, dental services, supplements and hospitals, while legal services ads remain banned except for general legal education.
SE Ranking found ads appeared on 28.69% of commercial healthcare prompts tested in July 2026, versus 2.64% in Google's AI Mode for the same test set.
Advertiser disclosure: some links in our articles are affiliate links, and CMO Mag may earn a commission or referral fee if you sign up or buy through them, at no cost to you. It never affects our editorial coverage. See our advertising & affiliate policy.
More in Advertising
View all
YouTube Doubles Shorts Payout Bar, Sets 2027 Deadline
YouTube is rewriting Partner Program terms effective February 1, 2027, doubling entry thresholds for new creators and adding a monthly view minimum for Shorts payouts. Current partners have until January 31 to re-sign or lose monetization.
Publicis Buys LiveRamp, Rivals Ditch It Within Days
Publicis's $2.167 billion purchase of LiveRamp has ended shared identity infrastructure in ad tech: Omnicom moved up its exit date and WPP has already walked.
Nielsen Acquires DoubleVerify for $2.15B, Reshapes Ad Verification
Nielsen is buying DoubleVerify for $2.15 billion in cash, the second of the industry's two biggest independent verification firms to leave public markets in under a year.
Discussion
No comments yet. Be the first to say something worth reading.